Deciphera Pharmaceuticals (Schweiz) AG
- Sector unverified
- Rank 285 / 334
Deciphera Pharmaceuticals (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 1 human medicine, which places it 285 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 1 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Deciphera Pharmaceuticals (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 1 human medicine. The table shows 1 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
1 of 1 authorisation
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Qinlock 50 mg | 68199 | A | L01EX19 | 2021-10-07 |
Frequently asked questions
How many medicines does Deciphera Pharmaceuticals (Schweiz) AG have authorised in Switzerland?
Deciphera Pharmaceuticals (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 1 human medicine (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Deciphera Pharmaceuticals (Schweiz) AG based?
We have no confirmed Swiss address for Deciphera Pharmaceuticals (Schweiz) AG. We add it as soon as the commercial register or the company confirms it.
Is Deciphera Pharmaceuticals (Schweiz) AG a Swissmedic authorisation holder?
Yes. Deciphera Pharmaceuticals (Schweiz) AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.